激光泪道成形术联合抗代谢药物治疗复发性泪道阻塞疗效分析  

Clinical observation of lacrimal laser angioplasty combined with anti-metabolism drug treatment for recurrent lacrimal duct obstruction

作　　者：李强 曹东 杨兴旺 李博 高雪辉 

机构地区：[1]解放军第三中心医院眼科,宝鸡721004

出　　处：《中国实用眼科杂志》2010年第7期754-756,共3页Chinese Journal of Practical Ophthalmology

摘　　要：目的观察分析激光泪道成形术联合抗代谢药物治疗复发性泪道阻塞的疗效。方法对101例激光泪道成形术后复发病例实施激光泪道成形术联合抗代谢药物治疗。结果术后随访观察3月，治愈85只眼，占84．2％；好转11只眼，占10．9％，总有效率95％。失败5只眼，占4．9％。结论激光泪道成形术联合抗代谢药物治疗复发性泪道阻塞效果肯定，并发症少，值得推广。Objective To observe and analyze the results of lacrimal laser angioplasty combined with antimetabolites in the treatment of recurrent lacrimal duct obstruction. Methods One hundred and one recurrent lacrimal laser angioplasty cases were implemented lacrimal laser angioplasty combined with an- ti-metabolism drug treatment. Results Postoperative follow-up time were three months, of which 85 cured, accounted for 84.2%; 11 improvement; accounted for 10.9%, the total effective rate was 95%; 5 failed, ac- counted for 4.9%. Conclusions Lacrimal laser angioplasty combined with anti-metabolism drug treatment is effective for treatment of recurrent lacrimal duct obstruction and has few complications, it is worth promoting.

关 键 词：激光泪道成形术 抗代谢药物 复发性泪道阻塞 疗效分析 

分 类 号：R777.2[医药卫生—眼科]